✉ info@591daili.com☎ +86-18553102138
📞 WhatsApp中文
Home › Product Catalog › Momelotinib Hydrochlode

Momelotinib Hydrochlode

CAS 1841094-17-4C23H26Cl2N6O3MW 505.4

Momelotinib Hydrochlode (CAS 1841094-17-4) — formula C23H26Cl2N6O3, molecular weight 505.4; category organic chemicals.

Product Overview

CAS Number1841094-17-4
Molecular FormulaC23H26Cl2N6O3
Molecular Weight505.4
CategoryOrganic Chemicals

Technical Profile

What this product is

Momelotinib Hydrochlode is a carbon-based organic compound with CAS registry number 1841094-17-4 and molecular formula C23H26Cl2N6O3 (molecular weight 505.4), belonging to the organic chemicals segment of chemical raw materials.

Identification

CAS number: 1841094-17-4

Its molecular formula C23H26Cl2N6O3 comprises 23 C, 26 H, 2 Cl, 6 N, 3 O atoms.

Also known as: Momelotinib Hydrochlode · 盐酸莫洛替尼

Category: organic chemicals

Frequently Asked Questions

What is the CAS number of Momelotinib Hydrochlode?

The CAS registry number of Momelotinib Hydrochlode is 1841094-17-4.

What is the molecular formula and molecular weight of Momelotinib Hydrochlode?

Molecular formula C23H26Cl2N6O3, molecular weight 505.4.

What other names is Momelotinib Hydrochlode known by?

It is also registered under: Momelotinib Hydrochlode, 盐酸莫洛替尼.

Which category does Momelotinib Hydrochlode belong to?

Category: Organic Chemicals.

PubChem Public Data

Independent reference data for Momelotinib Hydrochlode (CAS 1841094-17-4), compiled from public chemistry databases.

Registry identifiers across databases

CAS Registry Number1841094-17-4
PubChem CID102514733
Molecular formulaC23H26Cl2N6O3
IUPAC nameN-(cyanomethyl)-4-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]benzamide;hydrate;dihydrochloride
UNII (FDA)LDX8893L5D

Computed descriptors

Molecular Weight505.4
Hydrogen Bond Donor Count5
Hydrogen Bond Acceptor Count8
Rotatable Bond Count6
Exact Mass504.1443441
Monoisotopic Mass504.1443441
Topological Polar Surface Area104
Heavy Atom Count34

Documented uses on record

    Momelotinib Dihydrochloride MonohydrateMomelotinib dihydrochloride monohydrate is approved to treat:

    Synonyms and trade names

    Momelotinib dihydrochloride monohydrate; CYT-387 dihydrochloride monohydrate; LDX8893L5D; CYT-11387 dihydrochloride monohydrate; MOMELOTINIB HYDROCHLORIDE HYDRATE; Momelotinib hydrochloride hydrate (JAN); MOMELOTINIB HYDROCHLORIDE HYDRATE [JAN]; N-(Cyanomethyl)-4-(2-(4-(morpholin-4-yl)anilino)pyrimidin-4-yl)benzamide dihydrochloride monohydrate; N-(Cyanomethyl)-4-{2-[4-(morpholin-4-yl)anilino]pyrimidin-4-yl}benzamide dihydrochloride monohydrate; RefChem:159402; UNII-LDX8893L5D; Ojjaara; 1841094-17-4; Ojjaara (TN); Omjjara (TN); CHEMBL6068336

    GHS hazard classification

    Reported hazard statementsH302 (100%), H373 (100%)

    H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

    H373 (100%): May causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure]

    What the public record says

    Momelotinib Hydrochlode · CAS 1841094-17-4 · C23H26Cl2N6O3. UNII LDX8893L5D.

    Source: PubChem / Wikidata; the batch COA governs where values differ.

Request a Quote

✉ info@591daili.com☎ +86-18553102138📞 WhatsAppEmail InquiryWhatsApp Inquiry

Supplier: Jinan Shenghe Chemical Co., Ltd.

中文页面: 盐酸莫洛替尼

鲁ICP备19031700号-2